These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 18176598)

  • 1. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells and Toll-like receptors in tumor immunity.
    Wang RF; Peng G; Wang HY
    Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.
    Jarnicki AG; Conroy H; Brereton C; Donnelly G; Toomey D; Walsh K; Sweeney C; Leavy O; Fletcher J; Lavelle EC; Dunne P; Mills KH
    J Immunol; 2008 Mar; 180(6):3797-806. PubMed ID: 18322186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional control of regulatory T cells and cancer immunotherapy.
    Wang RF
    Semin Cancer Biol; 2006 Apr; 16(2):106-14. PubMed ID: 16423537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor ligands energize peptide vaccines through multiple paths.
    Celis E
    Cancer Res; 2007 Sep; 67(17):7945-7. PubMed ID: 17804699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
    Wang RF
    Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells as therapeutic vaccines against cancer.
    Banchereau J; Palucka AK
    Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents.
    Makkouk A; Abdelnoor AM
    Immunopharmacol Immunotoxicol; 2009; 31(3):331-8. PubMed ID: 19555209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.
    Smits EL; Ponsaerts P; Berneman ZN; Van Tendeloo VF
    Oncologist; 2008 Aug; 13(8):859-75. PubMed ID: 18701762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.
    Salem ML
    Immunol Lett; 2011 Jun; 137(1-2):9-14. PubMed ID: 21352854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
    Liu G; Zhao Y
    Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR based therapeutics.
    Dunne A; Marshall NA; Mills KH
    Curr Opin Pharmacol; 2011 Aug; 11(4):404-11. PubMed ID: 21501972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells and toll-like receptors in cancer therapy.
    Wang RF
    Cancer Res; 2006 May; 66(10):4987-90. PubMed ID: 16707417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and cancer.
    Wang HY; Wang RF
    Curr Opin Immunol; 2007 Apr; 19(2):217-23. PubMed ID: 17306521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.
    Goldman M
    Clin Exp Immunol; 2007 Feb; 147(2):208-16. PubMed ID: 17223960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.